We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cisco
CSCO
$443B
| $364M | 0.61% |
7,598,658
-80,413
| -1% | -$3.74M |
|
27
PepsiCo
PEP
$196B
| $348M | 0.58% |
2,548,806
-4,148
| -0.2% | -$565K |
|
28
Pfizer
PFE
$143B
| $344M | 0.58% |
9,250,004
+8,334
| +0.1% | +$297K |
|
29
Citigroup
C
$213B
| $307M | 0.51% |
3,846,476
-71,983
| -2% | -$5.32M |
|
30
Walmart Inc
WMT
$909B
| $306M | 0.51% |
7,721,388
+235,281
| +3% | +$9.34M |
|
31
Boeing
BA
$169B
| $291M | 0.49% |
892,921
-7,190
| -0.8% | -$2.55M |
|
32
Abbott
ABT
$188B
| $289M | 0.48% |
3,330,151
+53,419
| +2% | +$4.47M |
|
33
Adobe
ADBE
$105B
| $287M | 0.48% |
871,551
-9,181
| -1% | -$2.7M |
|
34
McDonald's
MCD
$193B
| $284M | 0.47% |
1,437,099
-2,979
| -0.2% | -$591K |
|
35
Medtronic
MDT
$112B
| $265M | 0.44% |
2,339,999
+23,553
| +1% | +$2.58M |
|
36
NVIDIA
NVDA
$4.6T
| $261M | 0.44% |
44,372,440
-157,600
| -0.4% | -$820K |
|
|
37
Bristol-Myers Squibb
BMY
$129B
| $254M | 0.43% |
3,960,508
+1,186,702
| +43% | +$68M |
|
38
Amgen
AMGN
$209B
| $251M | 0.42% |
1,042,399
-7,870
| -0.7% | -$1.73M |
|
39
Netflix
NFLX
$307B
| $244M | 0.41% |
7,545,080
-22,480
| -0.3% | -$667K |
|
40
Costco
COST
$432B
| $241M | 0.4% |
818,664
-4,624
| -0.6% | -$1.37M |
|
41
Salesforce
CRM
$154B
| $239M | 0.4% |
1,472,063
+4,888
| +0.3% | +$766K |
|
42
Accenture
ACN
$106B
| $238M | 0.4% |
1,130,070
-9,028
| -0.8% | -$1.76M |
|
43
Nike
NKE
$64.1B
| $233M | 0.39% |
2,295,141
-28,485
| -1% | -$2.69M |
|
44
Texas Instruments
TXN
$248B
| $228M | 0.38% |
1,779,116
-12,412
| -0.7% | -$1.53M |
|
45
NextEra Energy
NEE
$184B
| $227M | 0.38% |
3,745,608
+56,764
| +2% | +$3.31M |
|
46
Union Pacific
UNP
$174B
| $225M | 0.38% |
1,245,364
-30,308
| -2% | -$5.19M |
|
47
Honeywell
HON
$76.4B
| $225M | 0.38% |
1,346,983
+6,298
| +0.5% | +$1.03M |
|
48
PayPal
PYPL
$50.3B
| $224M | 0.38% |
2,074,874
-16,666
| -0.8% | -$1.74M |
|
49
Broadcom
AVGO
$1.76T
| $218M | 0.36% |
6,890,180
-57,520
| -0.8% | -$1.75M |
|
50
IBM
IBM
$213B
| $215M | 0.36% |
1,679,508
+5,068
| +0.3% | +$659K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.